| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| N I N G Han, N A Yu, L I Y. The mRNA stability of PIEZO1, regulated by METTL3 via m6A modification in a YTHDF2-dependent manner, facilitates the progression of diabetic retinopathy. The American journal of pathology. 2024-10-30. PMID:39476953. |
diabetic retinopathy (dr) is the major ocular complication of diabetes mellitus caused by chronic hyperglycemia, which leads to incurable blindness. |
2024-10-30 |
2024-11-02 |
mouse |
| Ju-Yeun Lee, Kunho Bae, Sangjun Lee, Sue K Par. Nationwide trends and incidence of blindness in patients with diabetic retinopathy identified using an age-period-cohort analysis. Eye (London, England). 2024-10-29. PMID:39468270. |
to estimate the epidemiologic trends of blindness in patients with diabetic retinopathy (dr) and investigate the age-, period-, and cohort-specific effects on blindness. |
2024-10-29 |
2024-10-31 |
Not clear |
| Yuan Ma, Yang Gu, Shuai Guo, Xin Qin, Shijie Wen, Nianfeng Shi, Weiwei Dai, Yiqiang Che. Grade-Skewed Domain Adaptation via Asymmetric Bi-Classifier Discrepancy Minimization for Diabetic Retinopathy Grading. IEEE transactions on medical imaging. vol PP. 2024-10-23. PMID:39441682. |
diabetic retinopathy (dr) is a leading cause of preventable blindness worldwide. |
2024-10-23 |
2024-10-26 |
Not clear |
| Huijun Zhou, Jingzhi Wang, Xuehao Cu. Causal effect of immune cells, metabolites, cathepsins, and vitamin therapy in diabetic retinopathy: a Mendelian randomization and cross-sectional study. Frontiers in immunology. vol 15. 2024-10-21. PMID:39430744. |
diabetic retinopathy (dr) is a major microvascular complication of diabetes and a leading cause of blindness worldwide. |
2024-10-21 |
2024-10-23 |
Not clear |
| Xiaofeng Du, Yanting Wang, Fan Ga. PSAT1 is upregulated by METTL3 to attenuate high glucose-induced retinal pigment epithelial cell apoptosis and oxidative stress. Diagnostic pathology. vol 19. issue 1. 2024-10-16. PMID:39407268. |
diabetic retinopathy (dr) is a major ocular complication of diabetes mellitus, and a significant cause of visual impairment and blindness in adults. |
2024-10-16 |
2024-10-18 |
Not clear |
| Xuelin Wang, Li Guo, Wei Zhang, Yuan Song, Hesham S Almoallim, Hossam M Aljawdah, Songhua Qua. Effect of madecassic acid on retinal oxidative stress, inflammation and Growth Factors in streptozotocin-induced diabetic rats. Biochemical and biophysical research communications. vol 735. 2024-10-12. PMID:39395370. |
diabetic retinopathy (dr) is the leading cause of blindness and visual loss in people with diabetes. |
2024-10-12 |
2024-10-15 |
rat |
| Huating Li, Weiping Jia, Stela Vujosevic, Charumathi Sabanayagam, Jakob Grauslund, Sobha Sivaprasad, Tien Yin Won. Current Research and Future Strategies for the Management of Vision-Threatening Diabetic Retinopathy. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2024-10-12. PMID:39395715. |
diabetic retinopathy (dr) is a major ocular complication of diabetes and the leading cause of blindness and visual impairment, particularly among adults of working-age adults. |
2024-10-12 |
2024-10-15 |
Not clear |
| Huating Li, Weiping Jia, Stela Vujosevic, Charumathi Sabanayagam, Jakob Grauslund, Sobha Sivaprasad, Tien Yin Won. Current Research and Future Strategies for the Management of Vision-Threatening Diabetic Retinopathy. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2024-10-12. PMID:39395715. |
this perspective reviewed the latest developments in research and innovation in three areas, first novel biomarkers (including advanced imaging modalities, serum biomarkers, and artificial intelligence technology) to predict the incidence and progression of dr, second, screening and early detection of referable dr and vision-threatening dr (vtdr), and finally, novel therapeutic strategies for vtdr, including diabetic macular oedema (dme), with the goal of reducing diabetic blindness. |
2024-10-12 |
2024-10-15 |
Not clear |
| Mingxia Tang, Wei Li. Tropisetron attenuates high glucose-induced oxidative stress and inflammation in ARPE-19 cells in vitro via regulating SIRT1/ROCK1 signaling. Drug development research. vol 85. issue 7. 2024-10-09. PMID:39381984. |
diabetic retinopathy (dr) is the leading cause of acquired blindness in diabetic patients. |
2024-10-09 |
2024-10-11 |
human |
| Mawdda Benhamza, Maznah Dahlui, Mas Ayu Sai. Determining direct, indirect healthcare and social costs for diabetic retinopathy management: a systematic review. BMC ophthalmology. vol 24. issue 1. 2024-10-01. PMID:39350064. |
diabetic retinopathy (dr) is a rapidly growing global public health threat; it affects 1 in 3 people with diabetes and is still the leading cause of blindness among the working-age population. |
2024-10-01 |
2024-10-03 |
Not clear |
| Masaya Koshizaka, Tomoaki Tatsumi, Fumiko Kiyonaga, Yoshinori Kosakai, Yoko Yoshinaga, Mami Shintani-Tach. Comparison of the Risk of Diabetic Retinopathy Between Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus in Japan: A Retrospective Analysis of Real-World Data. Diabetes therapy : research, treatment and education of diabetes and related disorders. 2024-09-30. PMID:39347896. |
diabetic retinopathy (dr), a microvascular complication of type 2 diabetes mellitus (t2dm), is a leading cause of blindness and has detrimental effects on patients' quality of life. |
2024-09-30 |
2024-10-02 |
Not clear |
| Jung Won Kwon, Kihwang Lee, Sang Wha Kim, Jisu Park, Jung Joo Hong, Jeong-Hwan Che, Seung Hyeok Seo. Therapeutic potential of histamine H Scientific reports. vol 14. issue 1. 2024-09-30. PMID:39349555. |
therapeutic potential of histamine h diabetic retinopathy (dr) is a prevalent complication of diabetes, often resulting in vision loss and blindness. |
2024-09-30 |
2024-10-03 |
Not clear |
| Md Nuho Ul Alam, Erfanul Hoque Bahadur, Abdul Kadar Muhammad Masum, Farzan M Noori, Md Zia Uddi. SwAV-driven diagnostics: new perspectives on grading diabetic retinopathy from retinal photography. Frontiers in robotics and AI. vol 11. 2024-09-30. PMID:39346742. |
if left untreated, dr can potentially result in blindness. |
2024-09-30 |
2024-10-02 |
Not clear |
| Shaikha M AlFalasi, Khuloud A Abdouli, Noura A Aldasht. Association of Anemia and Diabetic Retinopathy Among Patients With Type 2 Diabetes Mellitus: Retrospective Cross-Sectional Study. Cureus. vol 16. issue 8. 2024-09-30. PMID:39347127. |
diabetic retinopathy (dr) is a common microvascular complication that can result in a preventable cause of blindness. |
2024-09-30 |
2024-10-02 |
Not clear |
| Luís Mendes, Luísa Ribeiro, Inês Marques, Conceição Lobo, José Cunha-Va. Characterization and Automatic Discrimination between Predominant Hypoperfusion and Hyperperfusion Stages of NPDR. Journal of personalized medicine. vol 14. issue 9. 2024-09-28. PMID:39338230. |
diabetic retinopathy (dr) is a common diabetes complication that can lead to blindness through vision-threatening complications like clinically significant macular edema and proliferative retinopathy. |
2024-09-28 |
2024-10-01 |
Not clear |
| Lan Zhou, Hongyan Sun, Gongyi Chen, Cunzi Li, Dan Liu, Xurui Wang, Ting Meng, Zhenyou Jiang, Shu Yang, Ming-Ming Yan. Indoxyl sulfate induces retinal microvascular injury via COX-2/PGE Journal of translational medicine. vol 22. issue 1. 2024-09-28. PMID:39334140. |
indoxyl sulfate induces retinal microvascular injury via cox-2/pge diabetic retinopathy (dr), the principal cause of acquired blindness among the working-age population, is the most frequent microvascular complication of diabetes. |
2024-09-28 |
2024-10-01 |
Not clear |
| Qingbo Li, Peiyu Wang, Yi Gong, Manhong Xu, Manqiao Wang, Rong Luan, Juping Liu, Xiaorong Li, Yan Sha. α-Klotho prevents diabetic retinopathy by reversing the senescence of macrophages. Cell communication and signaling : CCS. vol 22. issue 1. 2024-09-27. PMID:39327553. |
diabetic retinopathy (dr) is a common microvascular complication of diabetes mellitus (dm) and a significant cause of acquired blindness in the working-age population worldwide. |
2024-09-27 |
2024-09-29 |
mouse |
| Qin Chen, Fen-Sheng Qiu, Wei Xie, Wen-Ying Yu, Zhao-An Su, Guang-Ming Qin, You-Kun Kang, Song-Lin Jiang, Chen-Huan Y. Gypenoside A-loaded mPEG-PLGA nanoparticles ameliorate high-glucose-induced retinal microvasculopathy by inhibiting ferroptosis. International journal of pharmaceutics. 2024-09-26. PMID:39326476. |
diabetic retinopathy (dr) is one of the chronic microvascular complications of type 2 diabetes mellitus (t2dm), which will cause retinal detachment and blindness without ideal therapies. |
2024-09-26 |
2024-09-29 |
mouse |
| Yi-Fan Yang, Ling Yuan, Xiang-Yang Li, Qian Liu, Wen-Jie Jiang, Tai-Qiang Jiao, Jia-Qing Li, Meng-Yi Ye, Yang Niu, Yi Na. Molecular mechanisms of Buqing granule for the treatment of diabetic retinopathy: Network pharmacology analysis and experimental validation. World journal of diabetes. vol 15. issue 9. 2024-09-16. PMID:39280184. |
its blindness rate is high; therefore, finding a reasonable and safe treatment plan to prevent and control dr is crucial. |
2024-09-16 |
2024-09-18 |
Not clear |
| Changzhuan Xu, Song He, Hailin L. An attentional mechanism model for segmenting multiple lesion regions in the diabetic retina. Scientific reports. vol 14. issue 1. 2024-09-12. PMID:39266650. |
diabetic retinopathy (dr), a leading cause of blindness in diabetic patients, necessitates the precise segmentation of lesions for the effective grading of lesions. |
2024-09-12 |
2024-09-15 |
Not clear |